Significance of I-123 metaiodobenzylguanidine (¹²³I-MIBG) lung activity in subjects with heart failure in comparison to healthy control subjects

By Gerson Myron   Dwivedi Alok   Abdallah Mouhamad   Shukla Rakesh   Jacobson Arnold  

Journal of Nuclear Cardiology, Vol. 20, Iss. 4, 2013-08 ,pp. : 592-599

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson’s and heart diseases

By Nakae Ichiro   Hayashi Hideki   Mitsunami Kenichi   Horie Minoru  

Annals of Nuclear Medicine, Vol. 27, Iss. 8, 2013-10 ,pp. : 737-747

Springer Publishing Company

Access to resources Recommend Favorite

Variations in ¹²³I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation

By Verberne Hein   Habraken Jan   Eck-Smit Berthe   Agostini Denis   Jacobson Arnold  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 3, 2008-03 ,pp. : 547-553

Springer Publishing Company

Access to resources Recommend Favorite

Feasibility of [¹²³I]-meta-iodobenzylguanidine dynamic 3-D kinetic analysis in vivo using a CZT ultrafast camera: preliminary results

By Tinti Erica   Positano Vincenzo   Giorgetti Assuero   Marzullo Paolo  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 41, Iss. 1, 2014-01 ,pp. : 167-173

Springer Publishing Company

Access to resources Recommend Favorite

Targeting murine heart and brain: visualisation conditions for multi-pinhole SPECT with 99m Tc- and 123 I-labelled probes

By Pissarek M.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 36, Iss. 9, 2009-09 ,pp. : 1495-1509

Springer Publishing Company

Access to resources Recommend Favorite